Organism 173497 - Chelidonium majus (PAPAVERACEAE)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.
Search for all experiments on this taxon

Organism Details

PropertyValue
Taxon4619
FamilyPAPAVERACEAE
GenusCHELIDONIUM
SpeciesMAJUS
Species authorityL.
Subspecies
Subspecies authority
Comment
CitationHABERLEIN,H: TSCHIERSCH,KP: BOONEN,G: HILLER,KO:. (1996). CHELIDONIUM MAJUS L.: COMPONENTS WITH IN VITRO AFFINITY FOR THE GABA RECEPTOR. POSITIVE COOPERATION OF ALKALOIDS.. 62(3)
Geographical areaEUROPE
CountryGERMANY(CULT)

Experiments

Filters
Worktypes (5)
13
5
4
2
1
No match
Pharmacology (3)
13
2
6
No match
Compounds (10)
5
5
5
5
5
4
2
2
2
3
No match
21 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
610573
VOUCHER SPECIMEN REPORTED FOR
Chelidonium majus (PAPAVERACEAE)
610574
PHARMACOLOGY OF EXTRACT - IN VITRO
GABA RECEPTOR MODULATORY EFFECT
Chelidonium majus (PAPAVERACEAE)
610575
PHARMACOLOGY OF EXTRACT - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
610576
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
CHELERYTHRINE
610577
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
CHELERYTHRINE
610578
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
CHELERYTHRINE
610579
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
CHELERYTHRINE
610580
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chelidonium majus (PAPAVERACEAE)
SANGUINARINE
610581
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
SANGUINARINE
610582
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
SANGUINARINE
610583
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
SANGUINARINE
610584
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
SANGUINARINE
610585
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chelidonium majus (PAPAVERACEAE)
CRYPTOPINE,ALLO:
610586
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR MODULATORY EFFECT
Chelidonium majus (PAPAVERACEAE)
PROTOPINESTYLOPINECRYPTOPINE,ALLO:
610587
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chelidonium majus (PAPAVERACEAE)
PROTOPINE
610588
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Chelidonium majus (PAPAVERACEAE)
STYLOPINE
610589
ISOLATION AND IDENTIFICATION OF
Chelidonium majus (PAPAVERACEAE)
CHELIDONINE,ALPHA-HOMO:CHELIDONINECOPTISINEBERBERINE
610590
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
CHELIDONINE,ALPHA-HOMO:CHELIDONINECOPTISINEBERBERINE
610591
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
CHELIDONINE,ALPHA-HOMO:CHELIDONINECOPTISINEBERBERINE
610592
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
CHELIDONINE,ALPHA-HOMO:CHELIDONINECOPTISINEBERBERINE
610593
PHARMACOLOGY OF COMPOUND - IN VITRO
GABA RECEPTOR BLOCKING EFFECT
Chelidonium majus (PAPAVERACEAE)
CHELIDONINE,ALPHA-HOMO:CHELIDONINECOPTISINEBERBERINE
Show SPARQL Queries (1)